comparemela.com

CEL-SCI (NYSEAMERICAN:CVM – Get Rating) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Sunday. Separately, EF Hutton Acquisition Co. I restated a “buy” rating and set a $10.00 price objective on shares of CEL-SCI in a research report on Thursday, March 9th. CEL-SCI […]

Related Keywords

,Investors Services ,Ef Hutton Acquisition Co ,Nations Financial Group Inc ,Company Profile ,Get Rating ,Sigma Investments ,Nations Financial Group ,Leukocyte Interleukin ,Cel Sci ,Nyseamerican Cvm ,Icvm ,Medical ,Downgrade ,Stocknews Com ,

© 2024 Vimarsana

comparemela.com © 2020. All Rights Reserved.